Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitides Meningitis”

152 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 152 results

Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Not applicableStudy completedNCT04784845
What this trial is testing

Lactamica 9: Neisseria Lactamica Inoculation in Late Pregnancy

Who this might be right for
Microbial Colonization
University of Southampton 31
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Large-scale testing (Phase 3)Study completedNCT03476135
What this trial is testing

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 91
Large-scale testing (Phase 3)Study completedNCT00856297
What this trial is testing

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 389
Large-scale testing (Phase 3)Active Not RecruitingNCT06226714
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 840
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Large-scale testing (Phase 3)Study completedNCT01453348
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

Who this might be right for
Meningococcal DiseaseMeningococcal MeningitisHepatitis A+1 more
Novartis Vaccines 252
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT00450437
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Novartis Vaccines 3,539
Testing effectiveness (Phase 2)Study completedNCT03295318
What this trial is testing

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Who this might be right for
Meningitis, Meningococcal
Serum Institute of India Pvt. Ltd. 375
Early research (Phase 1)Study completedNCT04236960
What this trial is testing

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Who this might be right for
Meningococcal Infections
Walvax Biotechnology Co., Ltd. 100
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Large-scale testing (Phase 3)UnknownNCT04689165
What this trial is testing

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Testing effectiveness (Phase 2)UnknownNCT06337071
What this trial is testing

The ACYW135 Meningococcal Polysaccharide Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00657709
What this trial is testing

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Who this might be right for
Serogroup B Meningococcal Meningitis
Novartis Vaccines 3,630
Next Page